Castellum (CTM) grants director 100,000 options at $1.19
Castellum, Inc. (CTM) reported an insider equity award.
Rhea-AI Filing Summary
Castellum, Inc. (CTM) reported an insider equity award. Director Mark S. Alarie received a grant of 100,000 stock options on 11/11/2025 under the Second Amended 2021 Stock Incentive Plan. The options have an exercise price of $1.19 per share and an expiration date of 11/10/2032.
The award was granted as compensation for service on the Board and vests ratably over 20 months starting December 1, 2025. Following the transaction, Mr. Alarie beneficially owned 100,000 stock options, held directly. The option grant price was recorded at $0 as an award (no purchase cost at grant).
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options | 100,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. As compensation for his service as an independent member of the Board of Directors, Mr. Alarie received 100,000 stock options granted pursuant to the terms of the Castellum, Inc. Second Amended 2021 Stock Incentive Plan to purchase 100,000 shares of common stock which vest ratably over a period of twenty months commencing December 1, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Castellum (CTM) disclose in this Form 4?
What is the exercise price and term of the CTM options granted?
How do the CTM options vest for the director?
How many derivative securities does the director hold after the transaction?
Was there any cash paid for the CTM option grant?
Under which plan were the options granted?
AI-generated analysis. How Rhea-AI works. Not financial advice.